Machine signal
Active cluster sell — 10 distinct insiders, $25.1M, window ends Sep 23, 2026.
Figures computed from official regulatory filings — .
Analysttarget 57.34 USD (+88%) · consensus 4.64/5 · 13 buy · 1 hold · 0 sell
Ownershipinsiders 6.08% · institutions 93.23% · short 3.1% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Pharvaris N.V. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
70 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Monges Viviane | Exercise | $96.4K | SEC |
| Monges Viviane | Sell | $395.5K | SEC |
| Monges Viviane | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lu Peng | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schikan Johannes Gerardus Christiaan Petrus | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schikan Johannes Gerardus Christiaan Petrus | Exercise | $16K | SEC |
| Schikan Johannes Gerardus Christiaan Petrus | Sell | $29K | SEC |
| Lu Peng | Exercise | $117.3K | SEC |
| Nassif David W. | Sell | $218.8K | SEC |
| Nassif David W. | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Modig Berndt | Exercise | $10.5M | SEC |
| Bjork Elisabeth | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Glassman Robert | Exercise | $262.9K | Unusual size | SEC |
| Lu Peng | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schikan Johannes Gerardus Christiaan Petrus | Sell | $7M | Unusual size | SEC |
| Bjork Elisabeth | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lu Peng | Sell | $3.5M | Unusual size | SEC |
| Lesage Anne | Sell | $765.5K | SEC |
| Lu Peng | Exercise | $259K | Unusual size | SEC |
| Bjork Elisabeth | Exercise | $503.7K | SEC |
| Glassman Robert | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Glassman Robert | Sell | $558.8K | Unusual size | SEC |
| Bjork Elisabeth | Exercise | $317.5K | SEC |
| Lu Peng | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bjork Elisabeth | Sell | $2M | SEC |